We are live on ! Find out more
CPA

Capital Performance Advisors Portfolio holdings

AUM $1.5B
1-Year Est. Return 21.4%
This Fund
S&P 500
This Quarter Est. Return
+7.04%
1 Year Est. Return
+21.4%
3 Year Est. Return
+61.53%
5 Year Est. Return
10 Year Est. Return
AUM
$329M
AUM Growth
+$65.6M
Cap. Flow
+$47.9M
Cap. Flow %
14.56%
Top 10 Hldgs %
61.59%
Holding
2,901
New
2,799
Increased
53
Reduced
27
Closed
2

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$772K
2
NVDA icon
NVIDIA
NVDA
+$662K
3
AAPL icon
Apple
AAPL
+$589K
4
MSFT icon
Microsoft
MSFT
+$568K
5
AVGO icon
Broadcom
AVGO
+$431K

Sector Composition

Rank Sector Weight
1 Technology 10.08%
2 Financials 4.66%
3 Consumer Discretionary 2.92%
4 Healthcare 2.04%
5 Industrials 1.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INZY
2576
DELISTED
Inozyme Pharma
INZY
$183 ﹤0.01%
+35
New +$182
ARQ icon
2577
Arq
ARQ
$85.4M
$182 ﹤0.01%
+31
New +$189
AIV
2578
Aimco
AIV
$377M
$181 ﹤0.01%
+20
New +$178
DFH icon
2579
Dream Finders Homes
DFH
$1.43B
$181 ﹤0.01%
+5
New +$154
ORC
2580
Orchid Island Capital
ORC
$1.3B
$181 ﹤0.01%
+22
New +$181
PTC icon
2581
PTC
PTC
$14.5B
$181 ﹤0.01%
+1
New +$176
ISPR icon
2582
Ispire Technology
ISPR
$93M
$180 ﹤0.01%
+29
New +$210
FA icon
2583
First Advantage
FA
$3.43B
$179 ﹤0.01%
+9
New +$161
AVAH icon
2584
Aveanna Healthcare
AVAH
$2.11B
$177 ﹤0.01%
+34
New +$154
BCAL icon
2585
Southern California Bancorp
BCAL
$681M
$177 ﹤0.01%
+12
New +$175
NOG icon
2586
Northern Oil and Gas
NOG
$2.21B
$177 ﹤0.01%
+5
New +$191
TVGN icon
2587
Tevogen Bio Holdings
TVGN
$23.5M
$175 ﹤0.01%
+9
New +$263
ESTA icon
2588
Establishment Labs
ESTA
$2.71B
$173 ﹤0.01%
+4
New +$174
SGMO
2589
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$173 ﹤0.01%
+200
New +$147
CF icon
2590
CF Industries
CF
$18.4B
$172 ﹤0.01%
+2
New +$155
CG icon
2591
Carlyle Group
CG
$16.7B
$172 ﹤0.01%
+4
New +$168
OVID icon
2592
Ovid Therapeutics
OVID
$439M
$172 ﹤0.01%
+146
New +$153
EDR
2593
DELISTED
Endeavor Group Holdings, Inc.
EDR
$171 ﹤0.01%
+6
New +$165
HGBL icon
2594
Heritage Global
HGBL
$41.7M
$170 ﹤0.01%
+100
New +$205
GUTS icon
2595
Fractyl Health
GUTS
$127M
$170 ﹤0.01%
+67
New +$219
EZPW icon
2596
Ezcorp Inc
EZPW
$1.87B
$168 ﹤0.01%
+15
New +$164
INOD icon
2597
Innodata
INOD
$1.94B
$168 ﹤0.01%
+10
New +$168
JBIO
2598
Jade Biosciences
JBIO
$1.21B
$167 ﹤0.01%
+2
New +$129
SKT icon
2599
Tanger
SKT
$4.8B
$166 ﹤0.01%
+5
New +$146
CAL icon
2600
Caleres
CAL
$420M
$165 ﹤0.01%
+5
New +$182

Similar funds

Capital Performance Advisors's Q3 2024 Portfolio in Review

As of Q3 2024, Capital Performance Advisors held 2,901 positions worth $329M, up 25% from $263M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Capital Performance Advisors deployed $47.9M of net new capital in Q3 2024, opening 2,799 new positions and adding to 53 existing holdings. Its largest new stake was Broadcom: 2,686 shares worth $463K.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 8.6% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Dimensional US Core Equity 2 ETF, an estimated $521K trimmed.

  • Capital Performance Advisors's largest Q3 2024 buy was Broadcom: 2,686 shares worth $463K.
  • Capital Performance Advisors added most to Amazon in Q3 2024, an estimated $772K increase.
  • Capital Performance Advisors's biggest Q3 2024 reduction was Dimensional US Core Equity 2 ETF, cutting an estimated $521K.
  • Capital Performance Advisors fully exited Dimensional US Core Equity 1 ETF in Q3 2024, selling an estimated $497K.
  • Capital Performance Advisors's ten largest holdings make up 62% of its $329M portfolio in Q3 2024.
  • Capital Performance Advisors opened 2,799 new positions and closed 2 in Q3 2024.
  • Capital Performance Advisors's portfolio value rose 25% quarter-over-quarter to $329M.

Based on Capital Performance Advisors's 13F filing for Q3 2024, filed 1 Nov 2024.